All individuals carry a minimum of 1 copy of chromosome X.Despite being a relatively long chromosome with more than 150 million base pairs [1], similar in length to chromosome 8, association testing of genetic variants on chromosome X is still not routinely conducted.Genome-wide association studies (GWAS) have been used to identify a vast range of genomic loci of interest for a variety of complex human diseases and traits by quantifying genetic variants that are statistically associated with a given disease/trait [2,3].However, a lack of testing for variants on the X chromosome limits our ability to identify vital loci and subsequently understand potential mechanisms linked to this chromosome.There was a call for the inclusion of chromosome X into genome-wide association analyses presented in 2013.At that time, a scan of published GWAS from 2010 and 2011 showed that only 33% of the studies had tested variants on the X chromosome in their analyses [4].Despite this call for inclusion, the lack of representation of this chromosome has not improved according to a 2023 study.Of the 136 publications that submitted at least 1 summary statistics file to the NHGRI-EBI GWAS Catalog in 2021, only 25% reported chromosome X results [5].Indeed, there are several characteristics of this chromosome that make it unique compared to the autosomes, which can pose analytical challenges in association testing.Such challenges include how to account for X inactivation in individuals with an XX karyotype, how to model the hemizygous state of genotypes in individuals with an XY karyotype, or how to best code genotypes at the 2 pseudo-autosomal regions, short stretches at either end of the X with high homology with the Y chromosome, known as PAR1 and PAR2.The non-pseudo-autosomal region (nonPAR) denotes the middle sequence of the X chromosome.Furthermore, there are many well-used software that take GWAS summary statistics as input and ignore chromosome X information [6,7].This practice can make it difficult and unintuitive for researchers to run association testing on the X chromosome.Inclusion of chromosome X routinely in GWAS and downstream analyses will serve to enhance our understanding of the genetic contributors to complex diseases and traits.Here, we propose 8 tips to help move towards the inclusion of X in GWAS to provide a suggested set of concrete actions that can be taken to overcome the challenges or obstacles preventing routine analysis of this chromosome.
No takes yet. Share an insight, caveat, or question.
Bellavance et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: